Literature DB >> 8507113

Barrett's esophagus in children. Diagnosis and management.

H B Othersen1, R J Ocampo, E F Parker, C D Smith, E P Tagge.   

Abstract

OBJECTIVE: To determine the local prevalence and optimal therapy for children with Barrett's esophagus (BE), the authors studied children with esophageal strictures or gastroesophageal reflux (GER), or both, to diagnose BE and to follow after therapy. SUMMARY BACKGROUND DATA: Barrett's esophagus is seldom reported in children and therapeutic recommendations are unclear. Barrett's esophagus usually develops during the mucosal reparative process after acid-reflux injury to the esophageal mucosa. Risk factors for BE include conditions that are associated with GER such as mental retardation, esophageal stricture, esophageal atresia, and reversed gastric tube esophagoplasty. Barrett's syndrome increases the risk of esophageal adenocarcinoma by 30 to 40 times.
METHODS: All children with the risk factors had repeated esophagoscopy and multiple mucosal biopsies before and after therapy.
RESULTS: Eleven children have been documented with BE. The initial diagnoses were: GER, 5; esophageal atresia, 4; nasogastric intubation, 1; lye ingestion, 1. A gastric tube esophagoplasty had been performed in three patients with BE in the esophagus proximal to the anastomosis. Three children with mid-esophageal strictures and long segments of BE had total resection with colic interposition. An additional two patients with tight stricture were treated with colic-patch esophagoplasty without resection. The final three patients were treated with fundoplication alone.
CONCLUSIONS: Barrett's esophagus can be caused by acid from gastric tubes but responds to H2 blockers and diet. Resection eliminates BE; esophagoplasty only controls the stricture and must be accompanied by fundoplication. Barrett's esophagus persists in patients with fundoplication alone if reflux control is incomplete. The authors conclude that acid reflux must be controlled to treat BE successfully or the involved segment must be resected. Esophagogastrostomy apparently predisposes to BE.

Entities:  

Mesh:

Year:  1993        PMID: 8507113      PMCID: PMC1242875          DOI: 10.1097/00000658-199306000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  The oesophagus lined with gastric mucous membrane.

Authors:  P R ALLISON; A S JOHNSTONE
Journal:  Thorax       Date:  1953-06       Impact factor: 9.139

2.  The histologic spectrum of Barrett's esophagus.

Authors:  A Paull; J S Trier; M D Dalton; R C Camp; P Loeb; R K Goyal
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

3.  Esophageal adenocarcinoma after gastroesophageal reflux in children.

Authors:  J C Hoeffel; C Nihoul-Fekete; M Schmitt
Journal:  J Pediatr       Date:  1989-08       Impact factor: 4.406

4.  Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery.

Authors:  D L Brand; J T Ylvisaker; M Gelfand; C E Pope
Journal:  N Engl J Med       Date:  1980-04-10       Impact factor: 91.245

5.  Barrett's esophagus in children: a histologic and histochemical study of 11 cases.

Authors:  J E Cooper; L Spitz; B M Wilkins
Journal:  J Pediatr Surg       Date:  1987-03       Impact factor: 2.545

6.  Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy.

Authors:  S R Hamilton; J H Yardley
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

7.  Barrett's esophagus in three children after antileukemia chemotherapy.

Authors:  B B Dahms; M A Greco; S E Strandjord; F C Rothstein
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

8.  Barrett's esophagus in children: a consequence of chronic gastroesophageal reflux.

Authors:  B B Dahms; F C Rothstein
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

9.  Barrett's esophagus in an infant: a long standing history with final postsurgical regression.

Authors:  S Conti Nibali; G Barresi; G Tuccari; M Rivosecchi; G Magazzù
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Jul-Aug       Impact factor: 2.839

10.  The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.

Authors:  E Achkar; W Carey
Journal:  Am J Gastroenterol       Date:  1988-03       Impact factor: 10.864

View more
  2 in total

1.  Barrett's esophagus in children: what is the evidence?

Authors:  Maja Raicevic; Amulya K Saxena
Journal:  World J Pediatr       Date:  2018-07-10       Impact factor: 2.764

2.  Barrett's oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review.

Authors:  L Tullie; A Kelay; G S Bethell; C Major; N J Hall
Journal:  BJS Open       Date:  2021-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.